Abstract

High-dose interleukin-2 (HD IL-2) was approved in the 1990s after demonstrating durable complete responses (CRs) in some patients with metastatic melanoma (mM) and metastatic renal cell carcinoma (mRCC). Patients who...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The outcome and toxicity profile of checkpoint inhibitor immunotherapy subsequent to high-dose IL-2 in the treatment of metastatic melanoma and renal cell carcinoma.
Stephanie A Berg ... Hanh P Mai
Journal of Clinical Oncology | VOL. 37
Stephanie A Berg, et. al.Stephanie A Berg ... Hanh P Mai
10 Mar 2019
The MRC Randomised-controlled Trial of Interferon-α, Interleukin-2 and 5-Fluorouracil vs Interferon-α Alone in Patients with Advanced Renal cell Carcinoma (RE04): Rationale and Progress
J.M.G Larkin ... M.E Gore
Clinical oncology (Royal College of Radiologists (Great Britain)) | VOL. 17
J.M.G Larkin, et. al.J.M.G Larkin ... M.E Gore
01 Aug 2005
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
Elizabeth I Buchbinder ... Rene Gonzalez
Journal for ImmunoTherapy of Cancer | VOL. 7
Elizabeth I Buchbinder, et. al.Elizabeth I Buchbinder ... Rene Gonzalez
18 Feb 2019
High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features.
Tala Achkar ... Melissa Saul
PloS one | VOL. 12
Tala Achkar, et. al.Tala Achkar ... Melissa Saul
20 Dec 2017
View more papers

More From: JOURNAL OF INVESTIGATIVE MEDICINE

Paper Title
Journal
Date
Author
EXPRESS: Soluble Fms-Like Tyrosine Kinase-1 as an Endothelial Dysfunction Biomarker Associated with Pulmonary Hypertension in Adult Patients with Beta-Thalassemia Major.
Samah Fathy Abozeid ... Mahmoud Farouk Seliem
JOURNAL OF INVESTIGATIVE MEDICINE | VOL. -
Samah Fathy Abozeid, et. al.Samah Fathy Abozeid ... Mahmoud Farouk Seliem
02 Aug 2024
EXPRESS: Acute Respiratory Distress Syndrome: A Review of ARDS Across the Life Course.
Caleb Cave ... Sidharth Mahapatra
JOURNAL OF INVESTIGATIVE MEDICINE | VOL. -
Caleb Cave, et. al.Caleb Cave ... Sidharth Mahapatra
02 Aug 2024
EXPRESS: Dual Versus Triple Antithrombotic Therapy in Atrial Fibrillation and Acute Coronary Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials.
Enkhtsogt Sainbayar ... Kwan Lee
JOURNAL OF INVESTIGATIVE MEDICINE | VOL. -
Enkhtsogt Sainbayar, et. al.Enkhtsogt Sainbayar ... Kwan Lee
02 Aug 2024
EXPRESS: Antihistamine and COVID-19 outcomes in outpatients.
Soodabeh Samimi ... Yasaman Vazani
JOURNAL OF INVESTIGATIVE MEDICINE | VOL. -
Soodabeh Samimi, et. al.Soodabeh Samimi ... Yasaman Vazani
01 Aug 2024
View more papers